Interestingly, however, among the 'low' cardiovascular risk participants 7 had an elevated TnT and 35 had a normal TnT.
Although the numbers of patients are small, these data suggest that an elevated TnT in 'low' cardiovascular risk renal transplant recipients identifies a group who are at increased risk of all-cause mortality.
Undoubtedly, renal transplant recipients with high cardiovascular risk profiles should undergo aggressive riskfactor modification irrespective of their TnT level. However, the results of our study suggest that an elevated TnT level identifies a group of renal transplant recipients who are at increased risk of all-cause mortality and who may be overlooked if the risk assessment is based on the presence of traditional cardiovascular risk factors. TnT is a biochemical marker readily available in clinical practice that can enhance the current methods used to stratify risk in renal transplant recipients. An elevated TnT level can identify a subgroup of patients who may well benefit from more aggressive cardiovascular risk-factor modification. serum albumin (P < 0.001), intravenous iron (P = 0.001) and a mid-treatment dose of heparin (P = 0.046) were the only variables that were associated with increased risk of sepsis (which was predominantly Staphylococcus, Table 1 ) [9] . While our data were not perfect, it may still lend some clinical evidence that the heparin itself is the risk factor for biofilm production and sepsis. The effect of heparin on biofilm, however, might vary for various strains of Staphylococcus. Onder's work now suggests that such may not be the case, since elimination of heparin did not improve the successful eradication of sepsis but actually tended to decrease it. Does this suggest that heparin may not be a pathologic factor? Perhaps, yet unlike most series of CRS, Staphylococcus aureus was relatively uncommon in Onder's study and indeed only one case was assigned to the heparin arm. In contrast, both coagulase negative Staphylococcus and Enterobacter were four times as common infecting agents in the heparin arm as Staphylococcus aureus. Another investigator recently found that in vitro heparin caused detachment of Staphylococcus lugdunensis from catheter walls [10] , which could theoretically either inhibit biofilm formation [11] or alternatively promote sepsis through systemic dispersal of biofilm [12] . The unusual distribution of bacterial pathogens in Dr Onder's work may have therefore either distorted his results, or alternatively may have given us valuable insight into the lack of an effect heparin on CRS. 1. We certainly do agree with Dr Palmer's last remark in the reply on the need for further large-scale research on mineral and bone disorders in CKD, as also clearly stated in our Editorial Comments [1]. 2. It now appears in their reply that some of the rather strong conclusions in their meta-analysis, which we opposed, are modified and less strongly promoted. 3. Both Dr Palmer and Dr M. Tonelli refer in their reply to our Editorial Comment to situations, where therapeutic replacement may be harmful and they both mention 'e.g. oestrogen plus progestin after menopause.' We do agree with that, but it is, however, not the correct clinical situation to use for comparison with vitamin D deficiency in uraemic patients, as neither calcitriol nor EPO replacement therapy of uraemic patients should be compared to pharmacological hormone replacement therapy for post-menopausal women. Vitamin D deficiency should rather be compared with hormone substitution therapy of ovariectomized young women. 4. As pointed out in our editorial, Dr Palmer et al. correctly mentioned in their meta-analysis a number of limitations to their study [2] . In spite of this, and in spite of the fact that none of the studies in the meta-analysis were either powered or designed to evaluate clinically relevant outcomes, such as mortality, Dr Palmer et al. continued to draw some rather powerful conclusions. In our opinion, their conclusions should have been much more moderate or maybe the authors should even have considered, whether the data in their meta-analysis were of too poor quality to warrant publication. It could instead have been turned into a Letter to the Editor and/or to the authorities stressing the need for good RCTs in this scientific field.
Reply to Dr M. Tonelli
We thank Dr Tonelli for his response to our critical edito- 
